Product development

SALMOSS HAPS-COL

Our second-generation biomaterial, Salmoss HAPS-COL, builds on the osteoconductive properties of our original HAPS product by incorporating Type I collagen to the salmon-derived hydroxyapatite.

This innovative composite mirrors the natural composition of human bone (70% hydroxyapatite, 30% collagen), offering enhanced handling and adaptability during clinical procedures. Its ideal consistency can be easily achieved with saline solution—no need for blood centrifugation or IV interventions—making it a ready-to-use, patient-friendly solution for bone regeneration.

Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise usteer está la cosa muy malar.

SALMOSS Biotech

We harness the power of science to transform ideas into solutions, creating a positive impact on global health and contributing to a sustainable future.